Symbol:
Slc47a2
Name:
solute carrier family 47 member 2
RGD ID:
1562382
Description:
Predicted to enable organic cation transmembrane transporter activity and polyspecific organic cation:proton antiporter activity. Predicted to be involved in organic cation transport. Predicted to be located in plasma membrane. Predicted to be active in membrane. Orthologous to human SLC47A2 (solute carrier family 47 member 2); PARTICIPATES IN metformin pharmacokinetics pathway; INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; bisphenol A; Cuprizon.
Type:
protein-coding
RefSeq Status:
INFERRED
Previously known as:
LOC497921; multidrug and toxin extrusion protein 2; RGD1562382; similar to novel protein; solute carrier family 47 (multidrug and toxin extrusion), member 2; solute carrier family 47, member 2
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 46,490,262 - 46,532,954 (-) NCBI GRCr8 mRatBN7.2 10 45,990,806 - 46,033,937 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 45,991,095 - 46,033,904 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 50,694,459 - 50,736,754 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 50,184,983 - 50,227,281 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 45,688,403 - 45,730,701 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 47,587,909 - 47,631,373 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 47,588,497 - 47,630,799 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 47,363,337 - 47,404,085 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 47,464,182 - 47,512,360 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 10 45,244,241 - 45,286,221 (-) NCBI Celera Cytogenetic Map 10 q22 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Slc47a2 Rat (R,R)-tramadol multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Tramadol inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat (S)-nicotine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Nicotine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat 17beta-estradiol multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of SLC47A2 mRNA and Estradiol promotes the reaction [ESR2 protein affects the expression of SLC47A2 mRNA] CTD PMID:20404318 and PMID:30165855 Slc47a2 Rat 17beta-estradiol increases expression ISO SLC47A2 (Homo sapiens) 6480464 Estradiol results in increased expression of SLC47A2 mRNA CTD PMID:23019147 Slc47a2 Rat 2,3',4,4',5-Pentachlorobiphenyl decreases expression ISO Slc47a2 (Mus musculus) 6480464 2 more ... CTD PMID:31388691 Slc47a2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO SLC47A2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC47A2 mRNA CTD PMID:20106945 Slc47a2 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of SLC47A2 mRNA CTD PMID:33387578 Slc47a2 Rat 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Verapamil inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] and Verapamil inhibits the reaction [SLC47A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:22419765 and PMID:27989701 Slc47a2 Rat 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile decreases activity ISO SLC47A2 (Homo sapiens) 6480464 Verapamil results in decreased activity of SLC47A2 protein CTD PMID:28629854 and PMID:31364238 Slc47a2 Rat 2-Ethyl-1,3-hexanediol multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 ethohexadiol affects the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat 2-palmitoylglycerol increases expression ISO SLC47A2 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of SLC47A2 mRNA CTD PMID:37199045 Slc47a2 Rat 3-[[oxo(pyridin-4-yl)methyl]hydrazo]-N-(phenylmethyl)propanamide multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Nialamide inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat 3-Amino-1-methyl-5H-pyrido[4,3-b]indole decreases activity ISO SLC47A2 (Homo sapiens) 6480464 3-amino-1-methyl-5H-pyrido(4 and 3-b)indole results in decreased activity of SLC47A2 protein CTD PMID:30189235 Slc47a2 Rat agmatine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Agmatine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat aldehydo-D-glucose multiple interactions ISO Slc47a2 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC47A2 mRNA CTD PMID:37567420 Slc47a2 Rat amantadine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Amantadine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat amiloride multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Amiloride inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat amitriptyline multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Amitriptyline inhibits the reaction [SLC47A2 protein results in increased import of Tetraethylammonium] CTD PMID:28629854 Slc47a2 Rat atropine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Atropine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat Azoxymethane multiple interactions ISO Slc47a2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC47A2 mRNA CTD PMID:29950665 Slc47a2 Rat benzo[a]pyrene increases expression ISO SLC47A2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of SLC47A2 mRNA CTD PMID:20106945 Slc47a2 Rat benzo[a]pyrene affects methylation ISO SLC47A2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of SLC47A2 promoter CTD PMID:27901495 Slc47a2 Rat benzo[a]pyrene decreases expression ISO Slc47a2 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of SLC47A2 mRNA CTD PMID:23735875 Slc47a2 Rat bis(2-ethylhexyl) phthalate decreases expression ISO SLC47A2 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of SLC47A2 mRNA CTD PMID:31163220 Slc47a2 Rat bis(2-ethylhexyl) phthalate increases expression ISO Slc47a2 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of SLC47A2 mRNA CTD PMID:34319233 Slc47a2 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of SLC47A2 mRNA CTD PMID:25181051 Slc47a2 Rat bisphenol A decreases expression ISO Slc47a2 (Mus musculus) 6480464 bisphenol A results in decreased expression of SLC47A2 mRNA CTD PMID:32156529 Slc47a2 Rat bisphenol A multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC47A2 gene CTD PMID:31601247 Slc47a2 Rat cadmium atom increases uptake ISO SLC47A2 (Homo sapiens) 6480464 SLC47A2 protein results in increased uptake of Cadmium CTD PMID:27871888 Slc47a2 Rat cadmium atom increases response to substance ISO SLC47A2 (Homo sapiens) 6480464 SLC47A2 protein results in increased susceptibility to Cadmium CTD PMID:27871888 Slc47a2 Rat cadmium atom multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Cadmium inhibits the reaction [SLC47A2 protein results in increased uptake of Metformin] and Cimetidine inhibits the reaction [SLC47A2 protein results in increased uptake of Cadmium] CTD PMID:27871888 Slc47a2 Rat caffeine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Caffeine affects the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat cannabidiol decreases expression ISO SLC47A2 (Homo sapiens) 6480464 Cannabidiol results in decreased expression of SLC47A2 mRNA CTD PMID:33244087 Slc47a2 Rat chloramphenicol multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Chloramphenicol affects the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat cimetidine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Cimetidine inhibits the reaction [SLC47A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] and Cimetidine inhibits the reaction [SLC47A2 protein results in increased uptake of Cadmium] CTD PMID:21599003 and PMID:27871888 Slc47a2 Rat cinchonidine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 cinchonidine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat cinchonine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 cinchonine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat clonidine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Clonidine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat clonidine (amino form) multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Clonidine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat clonidine (imino form) multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Clonidine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat clothianidin decreases activity ISO SLC47A2 (Homo sapiens) 6480464 clothianidin results in decreased activity of SLC47A2 protein CTD PMID:31364238 Slc47a2 Rat creatinine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Creatinine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of SLC47A2 mRNA CTD PMID:27523638 Slc47a2 Rat cyclosporin A decreases expression ISO SLC47A2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SLC47A2 mRNA CTD PMID:20106945 Slc47a2 Rat D-glucose multiple interactions ISO Slc47a2 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC47A2 mRNA CTD PMID:37567420 Slc47a2 Rat dextran sulfate multiple interactions ISO Slc47a2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC47A2 mRNA CTD PMID:29950665 Slc47a2 Rat epoxiconazole increases expression ISO Slc47a2 (Mus musculus) 6480464 epoxiconazole results in increased expression of SLC47A2 mRNA CTD PMID:35436446 Slc47a2 Rat famotidine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Famotidine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat fructose multiple interactions ISO Slc47a2 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC47A2 mRNA CTD PMID:37567420 Slc47a2 Rat fulvestrant multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 [bisphenol A co-treated with Fulvestrant] results in increased methylation of SLC47A2 gene CTD PMID:31601247 Slc47a2 Rat genistein increases expression ISO SLC47A2 (Homo sapiens) 6480464 Genistein results in increased expression of SLC47A2 mRNA CTD PMID:23019147 Slc47a2 Rat glucose multiple interactions ISO Slc47a2 (Mus musculus) 6480464 [lard co-treated with Cholesterol and Dietary co-treated with Dietary Sucrose co-treated with Fructose co-treated with Glucose] results in decreased expression of SLC47A2 mRNA CTD PMID:37567420 Slc47a2 Rat Guanfacine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Guanfacine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat guanidine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Guanidine affects the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat histamine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Histamine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat imiquimod multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 imiquimod inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat ketoconazole multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Ketoconazole inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat lead(0) affects expression ISO SLC47A2 (Homo sapiens) 6480464 Lead affects the expression of SLC47A2 mRNA CTD PMID:28903495 Slc47a2 Rat mercury dichloride increases expression ISO Slc47a2 (Mus musculus) 6480464 Mercuric Chloride results in increased expression of SLC47A2 mRNA CTD PMID:27720909 Slc47a2 Rat metformin increases uptake ISO SLC47A2 (Homo sapiens) 6480464 SLC47A2 protein results in increased uptake of Metformin CTD PMID:22419765 more ... Slc47a2 Rat metformin multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Cadmium inhibits the reaction [SLC47A2 protein results in increased uptake of Metformin] more ... CTD PMID:22419765 more ... Slc47a2 Rat methylmercury chloride increases expression ISO Slc47a2 (Mus musculus) 6480464 methylmercuric chloride results in increased expression of SLC47A2 mRNA CTD PMID:27720909 Slc47a2 Rat midodrine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Midodrine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat N-methyl-4-phenylpyridinium multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] more ... CTD PMID:22419765 Slc47a2 Rat N-methyl-4-phenylpyridinium increases uptake ISO SLC47A2 (Homo sapiens) 6480464 SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium CTD PMID:22419765 Slc47a2 Rat N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Ranitidine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat naloxone multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Naloxone inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat nickel atom increases expression ISO SLC47A2 (Homo sapiens) 6480464 Nickel results in increased expression of SLC47A2 mRNA CTD PMID:24768652 and PMID:25583101 Slc47a2 Rat nicotine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Nicotine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat NMN zwitterion multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Nicotinamide Mononucleotide inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat Ondansetron multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Ondansetron inhibits the reaction [SLC47A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] and Ondansetron inhibits the reaction [SLC47A2 protein results in increased uptake of Metformin] CTD PMID:21599003 and PMID:24001450 Slc47a2 Rat ozone multiple interactions ISO Slc47a2 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of SLC47A2 mRNA CTD PMID:34911549 Slc47a2 Rat paracetamol decreases expression ISO SLC47A2 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SLC47A2 mRNA CTD PMID:29067470 Slc47a2 Rat paraquat multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Paraquat inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat phenformin multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Phenformin inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat phentolamine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Phentolamine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat procainamide multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Procainamide analog inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] and Procainamide inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat proguanil multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Proguanil inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat propranolol multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Propranolol inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat pyrimethamine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Pyrimethamine analog inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] more ... CTD PMID:22419765 and PMID:32305507 Slc47a2 Rat pyrimethamine decreases activity ISO SLC47A2 (Homo sapiens) 6480464 Pyrimethamine results in decreased activity of SLC47A2 protein CTD PMID:32305507 Slc47a2 Rat quinidine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Quinidine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat quinine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Quinine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat ranitidine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Ranitidine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat scopolamine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Scopolamine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat serotonin multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Serotonin inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat silicon dioxide decreases expression ISO SLC47A2 (Homo sapiens) 6480464 Silicon Dioxide analog results in decreased expression of SLC47A2 mRNA CTD PMID:25895662 Slc47a2 Rat sotorasib multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SLC47A2 mRNA CTD PMID:36139627 Slc47a2 Rat sulfadimethoxine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Sulfadimethoxine affects the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat sulfamerazine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Sulfamerazine affects the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat tacrine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Tacrine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat tetraethylammonium increases import ISO SLC47A2 (Homo sapiens) 6480464 SLC47A2 protein results in increased import of Tetraethylammonium CTD PMID:28629854 Slc47a2 Rat tetraethylammonium multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Amitriptyline inhibits the reaction [SLC47A2 protein results in increased import of Tetraethylammonium] more ... CTD PMID:22419765 more ... Slc47a2 Rat tetraethylammonium increases uptake ISO SLC47A2 (Homo sapiens) 6480464 SLC47A2 protein results in increased uptake of Tetraethylammonium CTD PMID:27989701 and PMID:32305507 Slc47a2 Rat thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of SLC47A2 mRNA CTD PMID:34492290 Slc47a2 Rat ticlopidine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Ticlopidine affects the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat titanium dioxide multiple interactions ISO Slc47a2 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in increased expression of SLC47A2 mRNA CTD PMID:29950665 Slc47a2 Rat titanium dioxide decreases expression ISO SLC47A2 (Homo sapiens) 6480464 titanium dioxide results in decreased expression of SLC47A2 mRNA CTD PMID:34973136 Slc47a2 Rat tramadol multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Tramadol inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat trametinib multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of SLC47A2 mRNA CTD PMID:36139627 Slc47a2 Rat trichlormethiazide multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Trichlormethiazide affects the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat trimethoprim multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Trimethoprim inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat triptonide increases expression ISO Slc47a2 (Mus musculus) 6480464 triptonide results in increased expression of SLC47A2 mRNA CTD PMID:33045310 Slc47a2 Rat tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Atropine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat tyramine multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Tyramine inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] CTD PMID:22419765 Slc47a2 Rat valproic acid increases methylation ISO SLC47A2 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of SLC47A2 gene CTD PMID:29154799 Slc47a2 Rat verapamil decreases activity ISO SLC47A2 (Homo sapiens) 6480464 Verapamil results in decreased activity of SLC47A2 protein CTD PMID:28629854 and PMID:31364238 Slc47a2 Rat verapamil multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 Verapamil inhibits the reaction [SLC47A2 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] and Verapamil inhibits the reaction [SLC47A2 protein results in increased uptake of Tetraethylammonium] CTD PMID:22419765 and PMID:27989701 Slc47a2 Rat zafirlukast multiple interactions ISO SLC47A2 (Homo sapiens) 6480464 zafirlukast inhibits the reaction [SLC47A2 protein results in increased uptake of 4-(4-dimethylaminostyryl)-1-methylpyridinium] CTD PMID:21599003
(R,R)-tramadol (ISO) (S)-nicotine (ISO) 17beta-estradiol (ISO) 2,3',4,4',5-Pentachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2-(3,4-dimethoxyphenyl)-5-\{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino\}-2-(propan-2-yl)pentanenitrile (ISO) 2-Ethyl-1,3-hexanediol (ISO) 2-palmitoylglycerol (ISO) 3-[[oxo(pyridin-4-yl)methyl]hydrazo]-N-(phenylmethyl)propanamide (ISO) 3-Amino-1-methyl-5H-pyrido[4,3-b]indole (ISO) agmatine (ISO) aldehydo-D-glucose (ISO) amantadine (ISO) amiloride (ISO) amitriptyline (ISO) atropine (ISO) Azoxymethane (ISO) benzo[a]pyrene (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) cadmium atom (ISO) caffeine (ISO) cannabidiol (ISO) chloramphenicol (ISO) cimetidine (ISO) cinchonidine (ISO) cinchonine (ISO) clonidine (ISO) clonidine (amino form) (ISO) clonidine (imino form) (ISO) clothianidin (ISO) creatinine (ISO) Cuprizon (EXP) cyclosporin A (ISO) D-glucose (ISO) dextran sulfate (ISO) epoxiconazole (ISO) famotidine (ISO) fructose (ISO) fulvestrant (ISO) genistein (ISO) glucose (ISO) Guanfacine (ISO) guanidine (ISO) histamine (ISO) imiquimod (ISO) ketoconazole (ISO) lead(0) (ISO) mercury dichloride (ISO) metformin (ISO) methylmercury chloride (ISO) midodrine (ISO) N-methyl-4-phenylpyridinium (ISO) N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine (ISO) naloxone (ISO) nickel atom (ISO) nicotine (ISO) NMN zwitterion (ISO) Ondansetron (ISO) ozone (ISO) paracetamol (ISO) paraquat (ISO) phenformin (ISO) phentolamine (ISO) procainamide (ISO) proguanil (ISO) propranolol (ISO) pyrimethamine (ISO) quinidine (ISO) quinine (ISO) ranitidine (ISO) scopolamine (ISO) serotonin (ISO) silicon dioxide (ISO) sotorasib (ISO) sulfadimethoxine (ISO) sulfamerazine (ISO) tacrine (ISO) tetraethylammonium (ISO) thioacetamide (EXP) ticlopidine (ISO) titanium dioxide (ISO) tramadol (ISO) trametinib (ISO) trichlormethiazide (ISO) trimethoprim (ISO) triptonide (ISO) tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate (ISO) tyramine (ISO) valproic acid (ISO) verapamil (ISO) zafirlukast (ISO)
Slc47a2 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 10 46,490,262 - 46,532,954 (-) NCBI GRCr8 mRatBN7.2 10 45,990,806 - 46,033,937 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 10 45,991,095 - 46,033,904 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 10 50,694,459 - 50,736,754 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 10 50,184,983 - 50,227,281 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 10 45,688,403 - 45,730,701 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 10 47,587,909 - 47,631,373 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 10 47,588,497 - 47,630,799 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 10 47,363,337 - 47,404,085 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 10 47,464,182 - 47,512,360 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 10 45,244,241 - 45,286,221 (-) NCBI Celera Cytogenetic Map 10 q22 NCBI
SLC47A2 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 17 19,678,317 - 19,718,979 (-) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 17 19,678,288 - 19,718,979 (-) Ensembl GRCh38 hg38 GRCh38 GRCh37 17 19,581,630 - 19,622,292 (-) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 17 19,522,220 - 19,560,635 (-) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 17 16,994,973 - 17,033,389 (-) NCBI Celera Cytogenetic Map 17 p11.2 NCBI HuRef 17 18,960,725 - 18,998,919 (-) NCBI HuRef CHM1_1 17 19,590,477 - 19,628,892 (-) NCBI CHM1_1 T2T-CHM13v2.0 17 19,626,936 - 19,667,598 (-) NCBI T2T-CHM13v2.0
Slc47a2 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 11 61,192,453 - 61,233,686 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 11 61,192,457 - 61,233,686 (-) Ensembl GRCm39 Ensembl GRCm38 11 61,301,627 - 61,342,860 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 11 61,301,631 - 61,342,860 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 11 61,115,133 - 61,156,362 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 11 61,117,826 - 61,159,055 (-) NCBI MGSCv36 mm8 MGSCv36 11 61,731,316 - 61,772,552 (-) NCBI MGSCv36 mm8 Cytogenetic Map 11 B2 NCBI cM Map 11 37.96 NCBI
SLC47A2 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 19 54,668,935 - 54,716,956 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 17 59,480,780 - 59,528,679 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 17 31,412,990 - 31,454,667 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 17 36,560,835 - 36,599,133 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 17 36,560,881 - 36,599,133 (+) Ensembl panpan1.1 panPan2
SLC47A2 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 5 40,491,306 - 40,515,430 (+) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 5 40,491,933 - 40,540,136 (+) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 5 40,633,185 - 40,659,630 (+) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 5 40,597,303 - 40,623,761 (+) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 5 40,597,930 - 40,620,090 (+) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 5 40,568,675 - 40,595,116 (+) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 5 40,514,315 - 40,540,758 (+) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 5 40,706,986 - 40,733,428 (+) NCBI UU_Cfam_GSD_1.0
SLC47A2 Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 12 59,920,770 - 59,935,894 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 12 59,919,553 - 59,935,895 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 12 62,609,846 - 62,627,746 (-) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
SLC47A2 Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 16 18,240,876 - 18,281,634 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 16 18,242,392 - 18,279,930 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666059 2,566,025 - 2,606,428 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
.
Predicted Target Of
Count of predictions: 121 Count of miRNA genes: 101 Interacting mature miRNAs: 107 Transcripts: ENSRNOT00000057907 Prediction methods: Microtar, Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
61441 Btemp1 Thermal response to stress QTL 1 4 body temperature trait (VT:0005535) core body temperature (CMO:0001036) 10 35392457 63642539 Rat 9589136 Insul27 Insulin level QTL 27 10.46 0.001 blood insulin amount (VT:0001560) plasma insulin level (CMO:0000342) 10 11474010 56474010 Rat 152025229 Scl83 Serum cholesterol level QTL 83 4.33 blood cholesterol amount (VT:0000180) 10 35710580 68663659 Rat 1578779 Tcas10 Tongue tumor susceptibility QTL 10 3.12 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 10 31297439 76297439 Rat 631564 Apr3 Acute phase response QTL 3 3.9 blood interleukin-6 amount (VT:0008595) plasma interleukin-6 level (CMO:0001927) 10 15275955 60275955 Rat 1298069 Bp168 Blood pressure QTL 168 5.5 blood pressure trait (VT:0000183) systolic blood pressure (CMO:0000004) 10 26521957 98003205 Rat 631552 Vetf2 Vascular elastic tissue fragility QTL 2 4.5 0.0002 aorta elastic tissue integrity trait (VT:0010556) artery internal elastic lamina non-tumorous lesion count (CMO:0001913) 10 41142633 86142633 Rat 631554 Bp133 Blood pressure QTL 133 0.005 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 743364 63851208 Rat 631557 Bp136 Blood pressure QTL 136 0.003 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 30632053 75632053 Rat 61325 Aia5 Adjuvant induced arthritis QTL 5 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 1298078 Stresp5 Stress response QTL 5 2.99 0.00025 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 10 42045676 104670812 Rat 1578761 Stresp21 Stress response QTL 21 3.3 thymus mass (VT:0004954) thymus wet weight (CMO:0000855) 10 6375746 51375746 Rat 2298544 Neuinf9 Neuroinflammation QTL 9 4.6 nervous system integrity trait (VT:0010566) spinal cord complement component 1, q subcomponent, B chain mRNA level (CMO:0002126) 10 5801990 62146030 Rat 61463 Bp12 Blood pressure QTL 12 6.3 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 41333258 86333258 Rat 8694173 Bw149 Body weight QTL 149 4.38 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 10 44441699 89441699 Rat 2300218 Hpcl2 Hepatic cholesterol level QTL 2 liver cholesterol amount (VT:0010498) liver cholesterol level (CMO:0001597) 10 45029650 95600334 Rat 1554317 Bmd4 Bone mineral density QTL 4 9.4 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 10 19816042 99406971 Rat 1598852 Anxrr19 Anxiety related response QTL 19 5.07 body movement coordination trait (VT:0005424) number of rearing movements in an experimental apparatus (CMO:0001752) 10 18167841 63167841 Rat 1581497 Esta1 Estrogen-induced thymic atrophy QTL 1 thymus mass (VT:0004954) thymus wet weight (CMO:0000855) 10 21329805 61345413 Rat 2313095 Bss62 Bone structure and strength QTL 62 1.5 0.0001 tibia size trait (VT:0100001) tibia midshaft cross-sectional area (CMO:0001717) 10 5387014 50387014 Rat 724527 Bp148 Blood pressure QTL 148 0.0001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 28453136 73453136 Rat 1358897 Stresp6 Stress response QTL 6 4.17 0.022 blood norepinephrine amount (VT:0005663) plasma norepinephrine level (CMO:0001010) 10 35392267 64155584 Rat 1331762 Rf40 Renal function QTL 40 3.873 kidney blood vessel physiology trait (VT:0100012) absolute change in renal vascular resistance (CMO:0001900) 10 29299504 64155584 Rat 2300171 Bmd58 Bone mineral density QTL 58 4.9 0.0001 lumbar vertebra mineral mass (VT:0010511) volumetric bone mineral density (CMO:0001553) 10 26944628 71944628 Rat 61354 Pia10 Pristane induced arthritis QTL 10 0.01 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 2301967 Cm73 Cardiac mass QTL 73 4.55 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 10 14487011 89062041 Rat 2303118 Mamtr7 Mammary tumor resistance QTL 7 0.003 mammary gland integrity trait (VT:0010552) mammary tumor growth rate (CMO:0000344) 10 9658275 104670812 Rat 70188 BpQTLcluster1 Blood pressure QTL cluster 1 4.864 arterial blood pressure trait (VT:2000000) pulse pressure (CMO:0000292) 1 42323132 87323132 Rat 2313104 Bss61 Bone structure and strength QTL 61 0.9 0.0001 tibia area (VT:1000281) tibia midshaft cross-sectional area (CMO:0001717) 10 5387014 50387014 Rat 9590310 Scort19 Serum corticosterone level QTL 19 6.3 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 10 11474010 56474010 Rat 9589030 Epfw9 Epididymal fat weight QTL 9 19.24 0.001 epididymal fat pad mass (VT:0010421) epididymal fat pad weight to body weight ratio (CMO:0000658) 10 44441699 89441699 Rat 10402859 Bp381 Blood pressure QTL 381 0.002 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 27606468 72606468 Rat 2316949 Gluco60 Glucose level QTL 60 3.7 blood glucose amount (VT:0000188) blood glucose level (CMO:0000046) 10 14487011 107057807 Rat 70198 BpQTLcluster9 Blood pressure QTL cluster 9 2.94 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 42323132 87323132 Rat 6893352 Bw100 Body weight QTL 100 0.33 0.6 body mass (VT:0001259) body weight (CMO:0000012) 1 15906665 60906665 Rat 724556 Pur2 Proteinuria QTL 2 5.5 urine protein amount (VT:0005160) urine protein level (CMO:0000591) 10 22427500 90627625 Rat 8662860 Vetf10 Vascular elastic tissue fragility QTL 10 artery integrity trait (VT:0010639) number of ruptures of the internal elastic lamina of the abdominal aorta and iliac arteries (CMO:0002562) 10 6154182 73453136 Rat 2313066 Bss63 Bone structure and strength QTL 63 1.4 0.0001 tibia strength trait (VT:1000284) bone polar moment of inertia (CMO:0001558) 10 5387014 50387014 Rat 2313064 Bmd71 Bone mineral density QTL 71 0.9 0.0001 tibia mineral mass (VT:1000283) compact volumetric bone mineral density (CMO:0001730) 10 5387014 50387014 Rat 70223 Bp57 Blood pressure QTL 57 5 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 1 80676123 Rat 1354587 Kidm21 Kidney mass QTL 21 3.3 kidney mass (VT:0002707) right kidney wet weight (CMO:0000082) 10 15028513 60430477 Rat 6893350 Bw99 Body weight QTL 99 0.87 0.16 body mass (VT:0001259) body weight (CMO:0000012) 1 15906665 60906665 Rat 2317043 Aia7 Adjuvant induced arthritis QTL 7 3.82 joint integrity trait (VT:0010548) left rear ankle joint diameter (CMO:0002149) 10 37565079 82565079 Rat 70224 Eae3 Experimental allergic encephalomyelitis QTL 3 4.1 nervous system integrity trait (VT:0010566) experimental autoimmune encephalomyelitis incidence/prevalence measurement (CMO:0001046) 10 26521957 61345413 Rat 2317042 Aia20 Adjuvant induced arthritis QTL 20 3.38 joint integrity trait (VT:0010548) right rear ankle joint diameter (CMO:0002150) 10 37565079 82565079 Rat 2313081 Bss64 Bone structure and strength QTL 64 1.3 0.0001 tibia strength trait (VT:1000284) tibia total energy absorbed before break (CMO:0001736) 10 5387014 50387014 Rat 1331791 Cm31 Cardiac mass QTL 31 3.84606 heart mass (VT:0007028) heart wet weight (CMO:0000069) 10 29299504 107211142 Rat 2313087 Bmd80 Bone mineral density QTL 80 3.2 0.0001 tibia mineral mass (VT:1000283) total volumetric bone mineral density (CMO:0001728) 10 19606483 64606483 Rat 1354614 Hpcl1 Hepatic cholesterol level QTL 1 3.3 liver cholesterol amount (VT:0010498) liver cholesterol level (CMO:0001597) 10 35392267 51793994 Rat 631532 Cm50 Cardiac mass QTL 50 6.6 heart mass (VT:0007028) calculated heart weight (CMO:0000073) 10 17907113 51786432 Rat 1576319 Cia29 Collagen induced arthritis QTL 29 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 33973921 78973921 Rat 8552805 Bw145 Body weight QTL 145 2.2 body mass (VT:0001259) change in body weight to body weight ratio (CMO:0002216) 10 41944526 78307017 Rat 631267 Cia20 Collagen induced arthritis QTL 20 3.2 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 23444813 104060283 Rat 1600371 Mcs21 Mammary carcinoma susceptibility QTL 21 3 mammary gland integrity trait (VT:0010552) mammary tumor growth rate (CMO:0000344) 10 28875650 52200160 Rat 1576308 Schws1 Schwannoma susceptibility QTL 1 0.0041 nervous system integrity trait (VT:0010566) percentage of study population developing trigeminal nerve neurilemmomas during a period of time (CMO:0002017) 10 40035094 102359817 Rat 631269 Cia22 Collagen induced arthritis QTL 22 8.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 631268 Cia21 Collagen induced arthritis QTL 21 3.1 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 14487011 104060283 Rat 9590268 Scort13 Serum corticosterone level QTL 13 3.26 0.001 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 10 11474010 56474010 Rat 1576311 Pia26 Pristane induced arthritis QTL 26 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 31224026 75632053 Rat 631270 Cia23 Collagen induced arthritis QTL 23 3.9 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 40035094 104060283 Rat 7411614 Foco18 Food consumption QTL 18 0.001 eating behavior trait (VT:0001431) feed conversion ratio (CMO:0001312) 10 44441699 89441699 Rat 61427 Cia16 Collagen induced arthritis QTL 16 3.2 joint integrity trait (VT:0010548) joint inflammation composite score (CMO:0000919) 10 6357896 96121100 Rat 6893342 Cm78 Cardiac mass QTL 78 0.1 0.88 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 10 42876766 79813922 Rat 2292441 Bp308 Blood pressure QTL 308 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 10 27606468 72606468 Rat 2313055 Bw96 Body weight QTL 96 3.6 0.0001 body mass (VT:0001259) body weight (CMO:0000012) 10 19606483 64606483 Rat 631542 Bp82 Blood pressure QTL 82 6.8 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 10 26521957 98952741 Rat
RH134186
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 46,034,403 - 46,034,594 (+) MAPPER mRatBN7.2 Rnor_6.0 10 47,631,710 - 47,631,900 NCBI Rnor6.0 Rnor_5.0 10 47,404,996 - 47,405,186 UniSTS Rnor5.0 RGSC_v3.4 10 47,513,271 - 47,513,461 UniSTS RGSC3.4 Celera 10 45,287,132 - 45,287,322 UniSTS RH 3.4 Map 10 528.19 UniSTS Cytogenetic Map 10 q22 UniSTS Cytogenetic Map 10 q22-q23 UniSTS
BI288337
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 10 46,033,689 - 46,033,779 (+) MAPPER mRatBN7.2 Rnor_6.0 10 47,630,996 - 47,631,085 NCBI Rnor6.0 Rnor_5.0 10 47,404,282 - 47,404,371 UniSTS Rnor5.0 RGSC_v3.4 10 47,512,557 - 47,512,646 UniSTS RGSC3.4 Celera 10 45,286,418 - 45,286,507 UniSTS RH 3.4 Map 10 530.09 UniSTS Cytogenetic Map 10 q22 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
7
49
113
80
79
54
19
54
6
203
91
93
45
60
25
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000057907 ⟹ ENSRNOP00000054717
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 10 45,991,095 - 46,033,904 (-) Ensembl Rnor_6.0 Ensembl 10 47,588,497 - 47,630,799 (-) Ensembl
RefSeq Acc Id:
NM_001191920 ⟹ NP_001178849
RefSeq Status:
INFERRED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 46,490,832 - 46,532,954 (-) NCBI mRatBN7.2 10 45,991,370 - 46,033,493 (-) NCBI Rnor_6.0 10 47,588,497 - 47,630,799 (-) NCBI Rnor_5.0 10 47,363,337 - 47,404,085 (-) NCBI Celera 10 45,244,241 - 45,286,221 (-) NCBI
Sequence:
ATGGAGCCGGCCGAGGACAGCCTGGGCGCCGCCATCCAGCCCCCGGAGCTGGCCCCGGTACCGGAGCGCAGCCTGCGGATCCTGCTGGGCCTGCGAGAAGCGCTGTCCTCCGACGTGCGGCAGGAAGC
hide sequence
RefSeq Acc Id:
XM_039086568 ⟹ XP_038942496
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 46,490,262 - 46,532,954 (-) NCBI mRatBN7.2 10 45,990,806 - 46,033,937 (-) NCBI
RefSeq Acc Id:
XM_039086569 ⟹ XP_038942497
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 10 46,490,262 - 46,532,954 (-) NCBI mRatBN7.2 10 45,991,409 - 46,033,937 (-) NCBI
RefSeq Acc Id:
NP_001178849 ⟸ NM_001191920
- UniProtKB:
D4A4W2 (UniProtKB/TrEMBL)
- Sequence:
MEPAEDSLGAAIQPPELAPVPERSLRILLGLREALSSDVRQEAAALAALAGPVFLAQLMIFLISIVSSIFCGHLGKVELDAVTLAVSVVNVTGISVGTGLASACDTLMSQSFGGKNLKRVGVILQRGI
hide sequence
Ensembl Acc Id:
ENSRNOP00000054717 ⟸ ENSRNOT00000057907
RefSeq Acc Id:
XP_038942496 ⟸ XM_039086568
- Peptide Label:
isoform X1
RefSeq Acc Id:
XP_038942497 ⟸ XM_039086569
- Peptide Label:
isoform X2
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2016-02-24
Slc47a2
solute carrier family 47 member 2
Slc47a2
solute carrier family 47 (multidrug and toxin extrusion), member 2
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2013-08-02
Slc47a2
solute carrier family 47 (multidrug and toxin extrusion), member 2
Slc47a2
solute carrier family 47, member 2
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2008-02-29
Slc47a2
solute carrier family 47, member 2
RGD1562382_predicted
similar to novel protein (predicted)
Nomenclature updated to reflect human and mouse nomenclature
1299863 APPROVED
2006-03-07
RGD1562382_predicted
similar to novel protein (predicted)
LOC497921
similar to novel protein
Symbol and Name status set to approved
1299863 APPROVED
2006-02-09
LOC497921
similar to novel protein
Symbol and Name status set to provisional
70820 PROVISIONAL
